When it came to his philosophy of ‘giving while living’, US billionaire Chuck Feeney certainly walked the walk. Now, the late philanthropist has been honoured with his very own walkway on one of the sites his generosity helped build. In recognition of his contributions to healthcare and society, St James’s Hospital has established ‘The Feeney…
James Lemons, de 39 años, quiere que le extraigan la bala de su muslo para poder volver a trabajar. Sarai Holguín, de 71 años y originaria de México, ha aceptado la bala alojada cerca de su rodilla como su “compa”, es decir, una amiga cercana. A Mireya Nelson, de 15, la alcanzó una bala que…
Add topic to email alerts Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . “ data-action=”subscribe”> Subscribe We were unable to process your request. Please try again later. If you continue to have…
Novo Nordisk will test whether its GLP-1 drugs can help people with alcohol-associated liver disease, and, as part of that, will study if the treatments will change the amount of alcohol people drink. This appears to be the first time the company is getting involved in research to see if the booming class of GLP-1…
Naloxone, a drug used to reverse the effects of opioid overdose, is to be made more accessible across the UK, after the government announced plans to enable more services and individuals to provide take home supplies.1 Following a six week consultation earlier this year, the Department of Health and Social Care (DHSC) said … Source…
San Francisco is on the verge of passing a ban on “forever chemicals” in the protective clothing firefighters wear while battling blazes. City lawmakers are expected to pass an ordinance on Tuesday that will prohibit the use of firefighting gear made with per- and polyfluoroalkyl substances (PFAS). PFAS have been linked to health harms, including…
With pediatric inflammatory bowel disease (IBD) diagnoses on the rise globally, a clinical trial in Seattle aims to transform treatment approaches through deep molecular profiling. Recruitment has begun for the Seattle STRIDE study, a joint effort by Seattle Children’s Research Institute and the Allen Institute for Immunology. The trial aims to enroll 200 volunteers and…
Patients with type 2 diabetes and cognitive impairment and their caregivers could find short videos on how to talk to clinicians about deprescribing helpful, according to researchers presenting on May 10 at the 2024 annual meeting of the American Geriatrics Society. Clarissa Ferguson, MPH, program coordinator at UCSF School of Medicine, University of California, San…
Autism charity AsIAm is set to open two new hubs to provide information and support to autistic adults, children and families after receiving Government funding. The ‘Autism One Stop Shops’ aims to be coordinated, effective, neuro-affirmative evidence-based destinations, providing ‘drop in’ and structured supports. The new hubs will be located in healthcare regions CHO 7…
Doctors may soon be able to use blood tests to predict how primary progressive multiple sclerosis (PPMS) will worsen overtime for patients.1 This opens the door to earlier interventions and personalized treatment plans, eventually creating opportunities to slow the progression of the disease. Primary progressive multiple sclerosis is a specific type of multiple sclerosis (MS)…
